Want to join the conversation?
$ABBV 2Q15 Call: We've also continued to improve proficiency across our operations delivering roughly 800BPs in operating margin expansion vs. 2Q14, achieving an operating margin profile of 44.2% and we remain committed to improving this metric across our long-range plan.
Keep your eyes on $FLXN. This one could ascend rapidly. Great time to buy your favourite bio stocks. Make more $$$
$CRM on the pop today.. big bubble.
Slumping and down the drain... $HDSN. Flush out your holdings !
$KITE I am loving this one... really flying like a kite today :-)